The big picture: Simile, a Stanford spinout, has closed $200 million in Series B funding, reaching a $2 billion valuation just five months after its $100 million Series A. The Palo Alto startup develops foundation models that simulate human behavior for businesses, predicting responses before real-world deployment.
Why it matters:
- Market Disruption: The $80 billion global market research and consumer insights industry is undergoing disruption, shifting from generative content tools to predictive behavioral AI.
- Proactive Decision-Making: Simile enables enterprises to simulate customer, patient, or employee reactions to new products, campaigns, or policies at scale, mitigating the risks and costs of real-world pilots.
- Rapid Validation: The company’s swift funding trajectory, totaling over $300 million in under six months, signals the maturation of behavioral AI from academic concept to critical commercial infrastructure.
How it works:
- Foundation Models: Simile trains specialized foundation models designed to simulate human responses, based on research into interactive simulacra of human behavior.
- Scenario Simulation: These models run tens of millions of simulations for Fortune 100 companies, allowing them to test various scenarios, such as a healthcare insurer evaluating patient reactions to a new benefits plan.
- Actionable Insights: The platform provides direct, actionable predictions, complemented by a confidence model that scores the reliability of each simulation, addressing a key criticism of synthetic user research.
The catch: While Simile’s focus on predictive behavioral AI differentiates it from generative AI rivals like Glean, Harvey, and Writer, the inherent complexity and unpredictability of real-world human behavior pose a continuous challenge. The accuracy and generalizability of simulated human models require rigorous calibration, and the market for pre-emptive behavioral insights, though significant, must prove its quantifiable return on investment compared to faster content generation.
Key Facts
- Company: Simile
- Amount: $200M
- Round: Series B
- Investors: Greenoaks (lead), Index Ventures, Hanabi, Bain Capital Ventures, A*, Factory, CVS Health Ventures, Definition
- Founders: Joon Sung Park, Michael Bernstein, Percy Liang, Lainie Yallen
- Valuation: $2,000,000,000
- Sector: Behavioral AI
- Headquarters: Palo Alto

